607
Views
13
CrossRef citations to date
0
Altmetric
Review

Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/microsatellite stability-high colorectal cancer and shedding light on future approaches

&
Pages 735-742 | Received 12 Nov 2020, Accepted 02 Feb 2021, Published online: 18 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Inken Salewski, Julia Henne, Leonie Engster, Paula Krone, Bjoern Schneider, Caterina Redwanz, Heiko Lemcke, Larissa Henze, Christian Junghanss & Claudia Maletzki. (2022) CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors. OncoImmunology 11:1.
Read now

Articles from other publishers (12)

Jiajing Zhao, Jiazheng Quan, Weilin Chen & Xiaojun Xie. (2023) Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer. European Journal of Medical Research 28:1.
Crossref
Chuanxiu Zeng, Mengchao Wang, Shuqi Xie, Na Wang, Zhen Wang, Dan Yi, Fanming Kong & Liwei Chen. (2023) Clinical research progress on BRAF V600E-mutant advanced colorectal cancer. Journal of Cancer Research and Clinical Oncology 149:17, pages 16111-16121.
Crossref
Muhammet Ozer, Charan Thej Reddy Vegivinti, Masood Syed, Morgan E. Ferrell, Cyndi Gonzalez Gomez, Svea Cheng, Jennifer Holder-Murray, Tullia Bruno, Anwaar Saeed & Ibrahim Halil Sahin. (2023) Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm. Cancers 15:15, pages 3833.
Crossref
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree, Monica Malhotra, Roby Thomas, Dennis Hsu & Anwaar Saeed. (2023) Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future. JCO Oncology Practice 19:5, pages 251-259.
Crossref
Anwaar Saeed, Robin Park, Junqiang Dai, Raed Al-Rajabi, Anup Kasi, Joaquina Baranda, Stephen Williamson, Azhar Saeed, Jacob Ripp, Zachary Collins, Kelly Mulvaney, Molly Shugrue, Jeanette Firth-Braun, Andrew K. Godwin, Rashna Madan, Milind Phadnis & Weijing Sun. (2023) Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell Reports Medicine 4:2, pages 100916.
Crossref
Iman M. Talaat, Noha M. Elemam, Shroque Zaher & Maha Saber-Ayad. (2022) Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment. Frontiers in Medicine 9.
Crossref
Canan Karan, Elaine Tan, Humaira Sarfraz, Todd C. Knepper, Christine M. Walko, Seth Felder, Richard Kim & Ibrahim Halil Sahin. (2022) Human Epidermal Growth Factor Receptor 2–Targeting Approaches for Colorectal Cancer: Clinical Implications of Novel Treatments and Future Therapeutic Avenues. JCO Oncology Practice 18:8, pages 545-554.
Crossref
Xuan Zhang, Renfang Yang, Tao Wu, Xinyi Cai, Guoyu Li, Kun Yu, Yong Li, Rong Ding, Chao Dong, Jinsha Li, Ruixi Hu, Qing Feng & Yunfeng Li. (2022) Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI⁃H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study. Frontiers in Immunology 13.
Crossref
Ibrahim Halil Sahin, Kristen K. Ciombor, Luis A. Diaz, James Yu & Richard Kim. (2022) Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues. American Society of Clinical Oncology Educational Book:42, pages 242-253.
Crossref
Xuan Zhang, Tao Wu, Xinyi Cai, Jianhua Dong, Cuifeng Xia, Yongchun Zhou, Rong Ding, Renfang Yang, Jing Tan, Lijuan Zhang, Ya Zhang, Yuqin Wang, Chao Dong & Yunfeng Li. (2022) Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities. Frontiers in Immunology 13.
Crossref
Inken Salewski, Julia Henne, Leonie Engster, Bjoern Schneider, Heiko Lemcke, Anna Skorska, Peggy Berlin, Larissa Henze, Christian Junghanss & Claudia Maletzki. (2021) Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors. International Journal of Molecular Sciences 22:11, pages 5990.
Crossref
Jeeyun A. Kim, Rachel Ceccarelli & Christine Y. Lu. (2021) Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020). Journal of Personalized Medicine 11:3, pages 179.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.